Seite - (000411) - in Biomedical Chemistry: Current Trends and Developments

Taniguchi, H., Imai, K. (2012). [An overview of antibody therapy against cancer]. Nihon Rinsho, 70(12), 2087-2092. Tao, L., Zhang, K., Sun, Y., et al. (2012). Anti-epithelial cell adhesion molecule monoclonal antibody conjugated fluorescent nanoparticle biosensor for sensitive detection of colon cancer cells. Biosensors and Bioelectronics, 35(1), 186-192. Tardi, P., Johnstone, S., Harasym, N., et al. (2009). In vivo maintenance of synergistic cytarabine:Daunorubicin ratios greatly enhances therapeutic efficacy. Leukemia Research, 33(1), 129-139. Tarn, D., Ashley, C. E., Xue, M., et al. (2013). Mesoporous silica nanoparticle nanocarriers: Biofunctionality and biocompatibility. Accounts of Chemical Research, 46(3), 792-801. Tassa, C., Shaw, S. Y., Weissleder, R. (2011). Dextran-coated iron oxide nanoparticles: A versatile platform for targeted molecular imaging, molecular diagnostics, and therapy. Accounts of Chemical Research, 44(10), 842-852. Taurin, S., Nehoff, H., Greish, K. (2012). Anticancer nanomedicine and tumor vascular permeability; where is the missing link? Journal of Controlled Release, 164(3), 265-275. Tomic, S., Ethokic, J., Vasilijic, S., et al. (2014). Size-dependent effects of gold nanoparticles uptake on maturation and antitumor functions of human dendritic cells in vitro. PLoS One, 9(5), e96584. Torchilin, V. (2011). Tumor delivery of macromolecular drugs based on the epr effect. Advanced Drug Delivery Reviews, 63(3), 131-135. Torchilin, V. P. (2006). Multifunctional nanocarriers. Advanced Drug Delivery Reviews, 58(14), 1532-1555. Toy, R., Bauer, L., Hoimes, C., et al. (2014). Targeted nanotechnology for cancer imaging. Advanced Drug Delivery Reviews, 76C, 79-97. Trombetta, E. S., Mellman, I. (2005). Cell biology of antigen processing in vitro and in vivo. Annual Review of Immunology, 23, 975-1028. Valdez, R. A., McGuire, T. C., Brown, W. C., et al. (2000). An in vivo model to investigate lymphocyte-mediated immunity during acute hemoparasitic infections. Use of a monoclonal antibody to selectively deplete cd4+ t lymphocytes from thymectomized calves. Annals of the New York Academy of Sciences, 916, 233-236. van den Berg, J. H., Oosterhuis, K., Hennink, W. E., et al. (2010). Shielding the cationic charge of nanoparticle-formulated dermal DNA vaccines is essential for antigen expression and immunogenicity. Journal of Controlled Release, 141(2), 234-240. Varallyay, P., Nesbit, G., Muldoon, L. L., (2002). Comparison of two superparamagnetic viral- sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors. American Journal of Neuroradiology, 23(4), 510-519. Varga, N., Sutkeviciute, I., Guzzi, C., et al. (2013). Selective targeting of dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (dc-sign) with mannose-based glycomimetics: Synthesis and interaction studies of bis(benzylamide) derivatives of a pseudomannobioside. Chemistry, 19(15), 4786-4797. Vivek, R., Thangam, R., NipunBabu, V., et al. (2014). Multifunctional her2-antibody conjugated polymeric nanocarrier-based drug delivery system for multi-drug-resistant breast cancer therapy. ACS Applied Materials & Interfaces, 6(9), 6469-6480. Wang, M., Thanou, M. (2010). Targeting nanoparticles to cancer. Pharmacology Research, 62(2),